证券代码：688084 证券简称：晶品特装 公告编号：2023-028 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、会议召开情况 北京晶品特装科技股份有限公司（以下简称"公司"）第一届监事会第十三次 会议于 2023 年 8 月 6 日以专人送达方式发出通知，并于 2023 年 8 月 16 日在公 司会议室以现场表决的方式召开。会议应出席监事 3 人，实际出席监事 3 人，会 议由监事会主席王景文先生主持。会议的召集和召开程序符合《中华人民共和国 公司法》等法律、法规、部门规章以及《北京晶品特装科技股份有限公司章程》 （以下简称《公司章程》）的有关规定，会议做出的决议合法、有效。 二、监事会会议审议情况 （一）审议通过《关于<2023 年半年度报告>全文及摘要的议案》 北京晶品特装科技股份有限公司 第一届监事会第十三次会议决议公告 具体内容详见公司同日刊登于上海证券交易所网站（www.sse.com.cn）的《北 京晶品特装科技股份有限公司 2023 年半年度报告》及《北京晶品特装科技股份 有限公司 2023 年半年 ...

证券代码：688084 证券简称：晶品特装 公告编号：2023-029 北京晶品特装科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 募集资金基本情况 （一）实际募集资金金额、资金到账时间 根据中国证券监督管理委员会 2022 年 9 月 15 日核发的《关于同意北京晶品 特装科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2022〕2133 号），北京晶品特装科技股份有限公司（以下简称"公司"）向社会公众公开发行 人民币普通股（A 股）股票 1,900.00 万股（每股面值人民币 1 元），并于 2022 年 12 月 8 日在上海证券交易所科创板上市（以下简称"本次发行"）。本次发行的发 行价格为 60.98 元/股，本次发行募集资金总额 1,158,620,000.00 元，扣除公司不 含增值税保荐及承销费以及其他发行费用后募集资金净额为 1,067,276,861.41 元。 大华会计师事务所（特殊普通合伙）2022 年 12 月 5 日出具《验资报告》（大华 验字[2022]000839 ...

证券代码：688084 证券简称：晶品特装 公告编号：2023-027 北京晶品特装科技股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本次投资者说明会以网络互动形式召开，公司将针对 2023 年半年度的经营 成果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的 范围内就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 1 会议召开时间：2023 年 08 月 18 日(星期五) 下午 16:00-17:00 会议召开地点：上海证券交易所上证路演中心（网址： （一） 会议召开时间：2023 年 08 月 18 日 下午 16:00-17:00 （二） 会议召开地点：上证路演中心 （三） 会议召开方式：上证路演中心网络互动 重要内容提示： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 08 月 11 日(星期五)至 08 月 17 日(星期四)16:00 前登录上 ...

Financial Performance - The company's operating revenue for 2022 was ¥279,809,453.20, a decrease of 33.70% compared to ¥422,032,175.81 in 2021[22]. - Net profit attributable to shareholders for 2022 was ¥45,329,040.76, down 25.08% from ¥60,505,806.00 in 2021[22]. - The basic earnings per share for 2022 was ¥0.80, a decline of 26.61% from ¥1.09 in 2021[23]. - The total profit for the year was RMB 50.22 million, down 25.65% year-on-year, while the net profit attributable to shareholders was RMB 45.33 million, a decline of 25.08%[35]. - The total revenue for the year was 158,527,982.81 RMB, a decrease from 299,536,754.00 RMB in the previous year[120]. - The company achieved operating revenue of CNY 279.81 million, a decrease of 33.70% compared to the previous year[107]. - The net profit attributable to shareholders was CNY 45.33 million, down 25.08% year-on-year[107]. - The gross profit margin for the main business was 40.06%, an increase of 12.15 percentage points year-on-year[103]. - The gross profit margin for the defense and military industry was 38.37%, an increase of 11.41 percentage points compared to the previous year, despite a revenue decline of 37.83%[113]. Research and Development - The company's R&D expenditure as a percentage of operating revenue rose to 15.47% in 2022, an increase of 10.20 percentage points from 5.27% in 2021[23]. - Research and development (R&D) investment reached RMB 43.28 million, an increase of 94.60% compared to the previous year, with R&D personnel accounting for 23.83% of the total workforce[35]. - The total R&D investment for the year was 43,283,159.45 CNY, compared to 22,242,062.30 CNY in the previous year[82]. - The average salary of R&D personnel increased to 241,178.63 CNY, up from 147,298.26 CNY in the previous year[90]. - The company has developed advanced technologies in optical reconnaissance and military robotics, leading to successful bids in military procurement[92]. - The company aims to enhance its core competitiveness by increasing investment in R&D to meet the demands of unmanned and intelligent military equipment[91]. - The company is focusing on the development of next-generation human-machine collaboration technologies, with several patents authorized in simulation and navigation technologies during the reporting period[80]. Market Expansion and Strategy - The company actively expanded its market presence, particularly in the military sector, and developed products such as AR glasses and bomb disposal robots, enhancing its user base[42]. - A new market development team was established to strengthen international promotion of products, particularly targeting military trade customers[42]. - The company has actively expanded its overseas market, gaining significant attention from major clients[59]. - The company aims to build a comprehensive research and production system for optical reconnaissance and military robotics, enhancing its technological capabilities[61]. - The company plans to continue expanding its market presence and enhancing product offerings in response to changing customer demands[115]. - The company is exploring potential acquisitions to enhance its product portfolio, with a budget of 500 million RMB allocated for this purpose[170]. Corporate Governance - The company has received a standard unqualified audit report from Da Hua Accounting Firm[7]. - The company has confirmed that all board members attended the board meeting[7]. - The company has established specialized committees under the board, including the Audit Committee, Nomination Committee, Compensation and Assessment Committee, and Strategy Committee[185]. - All proposals at the 2021 Annual General Meeting were approved without any rejections[162]. - The company has not faced any penalties from securities regulatory authorities in the past three years[181]. - The company emphasizes the importance of maintaining effective communication with investors and ensuring compliance with information disclosure regulations[160]. Risk Management - The company has detailed potential risks and countermeasures in its annual report, emphasizing the importance of investor awareness[4]. - The company faces risks related to the loss of core technical personnel, which could adversely affect profitability[95]. - There were no dissenting opinions from the supervisory board regarding the company's risk management during the reporting period[188]. Dividend Policy - The company plans to distribute a cash dividend of 3 RMB per 10 shares, totaling approximately 22.7 million RMB, which represents 50.07% of the net profit attributable to shareholders[5]. - The proposed cash dividend is CNY 3 per 10 shares, totaling CNY 22,697,719.80 (including tax), which represents 50.07% of the net profit attributable to shareholders[195]. - The company strictly adhered to its cash dividend policy, ensuring transparency and compliance with regulations[196]. Intellectual Property - The company has obtained a total of 30 invention patents, 52 utility model patents, and 19 design patents, along with 83 software copyrights by the end of the reporting period[38]. - The company has filed for 2 invention patents and authorized 2 during the reporting period, bringing the total to 30 invention patents, 52 utility model patents, and 19 design patents[78]. - The company has a total of 213 intellectual property rights, including 184 granted, reflecting its strong commitment to innovation and technology development[80].

Financial Performance - The company's revenue for Q1 2023 was CNY 13,601,286.14, representing a year-on-year decrease of 55.17% due to macroeconomic factors and delayed product deliveries[5]. - The net loss attributable to shareholders was CNY 10,405,956.98, with a basic and diluted earnings per share of -0.14 CNY[5]. - Total revenue for Q1 2023 was ¥13,601,286.14, a decrease of 55.2% compared to ¥30,343,000.90 in Q1 2022[20]. - Net loss for Q1 2023 was ¥11,084,835.28, compared to a net loss of ¥2,928,778.02 in Q1 2022, indicating a significant increase in losses[21]. - The total operating profit for Q1 2023 was -¥13,353,156.34, worsening from -¥3,839,466.61 in Q1 2022[20]. Research and Development - Research and development expenses totaled CNY 12,143,453.46, accounting for 89.28% of revenue, an increase of 61.03 percentage points compared to the previous year[6]. - Research and development expenses rose to ¥12,143,453.46 in Q1 2023, up 41.5% from ¥8,573,894.32 in Q1 2022[20]. - The company is focusing on enhancing its product development and market expansion strategies, although specific new products or technologies were not detailed in the report[19]. Cash Flow and Assets - The net cash flow from operating activities was -CNY 31,475,641.18, reflecting improved cash management despite the net loss[5][10]. - Cash flow from operating activities showed a net outflow of ¥31,475,641.18 in Q1 2023, compared to a net outflow of ¥186,145,033.03 in Q1 2022[23]. - Cash and cash equivalents as of March 31, 2023, were RMB 636,573,319.45, down from RMB 1,377,098,910.47, a decrease of about 53.8%[15]. - Cash and cash equivalents at the end of Q1 2023 were ¥633,129,375.45, down from ¥1,373,654,966.47 at the beginning of the period[24]. - Total cash inflow from investment activities in Q1 2023 was ¥1,182,192,301.53, while cash outflow was ¥1,884,357,304.07, resulting in a net cash outflow of ¥702,165,002.54[24]. Shareholder Information - The company reported a total of 3,705 common shareholders at the end of the reporting period[12]. - The top three shareholders held a combined 51.30% of the company's shares, indicating concentrated ownership[13]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,913,003,870.99, a decrease of 4.00% from the previous year[6]. - The company's total liabilities decreased to RMB 235,706,091.76 from RMB 304,975,688.57, representing a reduction of about 22.7%[17]. - The total equity attributable to shareholders decreased to RMB 1,684,102,059.28 from RMB 1,693,938,016.26, indicating a decline of approximately 0.9%[17]. - The company's accounts receivable decreased to RMB 130,410,141.32 from RMB 168,985,043.29, a decline of approximately 22.8%[15]. - Inventory increased to RMB 155,038,430.26 from RMB 145,923,692.14, reflecting an increase of about 6.5%[15]. - The company reported a significant increase in trading financial assets, rising to RMB 713,948,506.32 from RMB 21,838,766.40, a substantial increase of approximately 3,272.5%[15]. - The company has maintained its capital reserve at RMB 1,521,692,745.62, unchanged from the previous period[17]. Future Outlook - The company plans to continue focusing on R&D and maintaining a stable order backlog to support future growth[6]. - The company had approximately CNY 133 million in unrecognized revenue from orders on hand as of the end of the reporting period, indicating stable business development[6]. - The company's short-term borrowings and other current liabilities were not specified, indicating a potential area for future financial strategy[17].

投资者可于 2023 年 04 月 18 日(星期二)至 04 月 24 日(星期一)16:00 前登录上 证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 jptz_ir@163.com 进 行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 证券代码：688084 证券简称：晶品特装 公告编号：2023-012 北京晶品特装科技股份有限公司 关于召开 2022 年度暨 2023 年第一季度业绩暨现金分 红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 北京晶品特装科技股份有限公司（以下简称"公司"）将于 2023 年 4 月 25 日 发布公司 2022 年度报告及 2023 年第一季度报告，为便于广大投资者更全面深入 地了解公司 2022 年度及 2023 年第一季度经营成果、财务状况，公司计划于 2023 年 04 月 25 日下午 16:00-17:00 举行 2022 年度暨 2023 年第一季度业绩暨现金分 红说明会，就投资者关心的问题进行交流。 一、 说明会类型 本 ...